ArticleResearch policy2021
The fall of the innovation empire and its possible rise through open science.
Article in Research policy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Revolutionising health and social care: innovative solutions for a brighter tomorrow - a systematic review of the literature.BMC health services research · 2024Pooled it
- Commentary: Making Patient Data Count-Opportunities and Challenges for Open Science in Clinical Psychology.Journal of clinical psychology · 2026Article
- Why We Should Recognize AI as an Inventor.Journal of bioethical inquiry · 2025Article
- Exploring regulatory flexibility to create novel incentives to optimize drug discovery.Frontiers in medicine · 2024Review
- 'Our project, your problem?' A case study of the WHO's mRNA technology transfer programme in South Africa.PLOS global public health · 2024Article
- The Impact of AUTOGEN and Similar Fine-Tuned Large Language Models on the Integrity of Scholarly Writing.The American journal of bioethics : AJOB · 2023Article
- Target 2035 - an update on private sector contributions.RSC medicinal chemistry · 2023Article
- Is open science a double-edged sword?: data sharing and the changing citation pattern of Chinese economics articles.Scientometrics · 2023Article
- Barriers to Treg therapy in Europe: From production to regulation.Frontiers in medicine · 2023Review
- University Technology Transfer Has Failed to Improve Access to Global Health Products during the COVID-19 Pandemic.Healthcare policy = Politiques de sante · 2022Article
- Article
- Open drug discovery in Alzheimer's disease.Alzheimer's & dementia (New York, N. Y.)Article
- Opening up mental health research.Journal of psychiatry & neuroscience : JPNArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is growing concern that the innovation system's ability to create wealth and attain social benefit is declining in effectiveness. This article explores the reasons for this decline and suggests a structure, the open science partnership, as one mechanism through which to slow down or reverse this decline. The article examines the empirical literature of the last century to document the decline. This literature suggests that the cost of research and innovation is increasing exponentially, that researcher productivity is declining, and, third, that these two phenomena have led to an overall flat or declining level of innovation productivity. The article then turns to three explanations for the decline - the growing complexity of science, a mismatch of incentives, and a balkanization of knowledge. Finally, the article explores the role that open science partnerships - public-private partnerships based on open access publications, open data and materials, and the avoidance of restrictive forms of intellectual property - can play in increasing the efficiency of the innovation system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.